Drawing for WHEN PATIENTS WIN, WE ALL WIN

USPTO serial 86739133

WHEN PATIENTS WIN, WE ALL WIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LAMONT, MIAH ROSENBERG
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WHEN PATIENTS WIN, WE ALL WIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark J. Murphy

MARK J. MURPHY Husch Blackwell Llp120 S Riverside Plz Fl 22Chicago, IL 60606-3912UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal and pharmaceutical preparations, namely, pharmaceutical medications for the treatment and prevention of cancers, melanoma, breast cancer, basal cell carcinoma, squamous cell carcinoma and cancers of the liver and topical medications for the treatment and prevention of psoriasis, atopic dermatitis and inflammatory dermatosesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 16, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 16, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 2, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 28, 2017EX2GSOU EXTENSION 2 GRANTED—
Feb 28, 2017EXT2SOU EXTENSION 2 FILED—
Feb 28, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2016EX1GSOU EXTENSION 1 GRANTED—
Sep 8, 2016EXT1SOU EXTENSION 1 FILED—
Sep 8, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 15, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 19, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 30, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 10, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2015DOCKASSIGNED TO EXAMINER—
Sep 1, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance